• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于控制牛血清白蛋白蛋白质释放的介孔硅酸钙

Mesoporous calcium silicate for controlled release of bovine serum albumin protein.

作者信息

Xue Weichang, Bandyopadhyay Amit, Bose Susmita

机构信息

W. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, WA 99164, USA.

出版信息

Acta Biomater. 2009 Jun;5(5):1686-96. doi: 10.1016/j.actbio.2009.01.012. Epub 2009 Jan 22.

DOI:10.1016/j.actbio.2009.01.012
PMID:19249262
Abstract

The purpose of this study is to synthesize mesoporous calcium silicate (CS or wollastonite, CaSiO(3)) and evaluate its possible application in protein/drug delivery. First, calcium silicate was synthesized by wet chemical method and then mesoporosity was created by acid modification of the synthesized CS particle using hydrochloric acid at pH 7, 4.5, and 0.5. The results showed that a hydrated silica gel with abundant Si-OH functional group formed on the surface of calcium silicate due to acid modification. This surface layer had mesoporous structure, with pore diameter between 4 and 5 nm. BET specific average surface area increased to 221, 333, and 356 m(2) g(-1) due to acid modification at pH 7, 4.5, and 0.5, respectively, whereas the surface area for unmodified CS particles was 65 m(2) g(-1). Protein adsorption studies indicated that mesoporous CS has higher ability to adsorb bovine serum albumin and lysozyme compared to unmodified particles. The release kinetics showed that proteins on mesoporous CS released sequentially over one week, whereas the proteins on unmodified particle followed burst release kinetics within a few hours. Human osteoblast cell-material interaction study showed that these materials were biocompatible and promoted excellent bone cell proliferation. In summary, this work has demonstrated the potential to produce mesoporous CS as a carrier for protein/drug delivery for bone regeneration and other biomedical applications.

摘要

本研究的目的是合成介孔硅酸钙(CS或硅灰石,CaSiO₃)并评估其在蛋白质/药物递送中的潜在应用。首先,通过湿化学方法合成硅酸钙,然后使用盐酸在pH值为7、4.5和0.5的条件下对合成的CS颗粒进行酸改性以产生介孔结构。结果表明,由于酸改性,在硅酸钙表面形成了具有丰富Si-OH官能团的水合硅胶。该表面层具有介孔结构,孔径在4至5纳米之间。由于在pH值为7、4.5和0.5时进行酸改性,BET比平均表面积分别增加到221、333和356 m² g⁻¹,而未改性的CS颗粒的表面积为65 m² g⁻¹。蛋白质吸附研究表明,与未改性颗粒相比,介孔CS具有更高的吸附牛血清白蛋白和溶菌酶的能力。释放动力学表明,介孔CS上的蛋白质在一周内依次释放,而未改性颗粒上的蛋白质在几小时内遵循突发释放动力学。人成骨细胞与材料相互作用研究表明,这些材料具有生物相容性并促进了优异的骨细胞增殖。总之,这项工作证明了生产介孔CS作为用于骨再生和其他生物医学应用的蛋白质/药物递送载体的潜力。

相似文献

1
Mesoporous calcium silicate for controlled release of bovine serum albumin protein.用于控制牛血清白蛋白蛋白质释放的介孔硅酸钙
Acta Biomater. 2009 Jun;5(5):1686-96. doi: 10.1016/j.actbio.2009.01.012. Epub 2009 Jan 22.
2
Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route.通过模板法制备发光和介孔 Eu3+/Tb3+掺杂硅酸钙微球作为药物载体。
Dalton Trans. 2011 Mar 7;40(9):1873-9. doi: 10.1039/c0dt01390k. Epub 2010 Dec 23.
3
A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier.一种作为药物载体的磁性、发光且具有介孔核壳结构的复合材料。
Biomaterials. 2009 Sep;30(27):4786-95. doi: 10.1016/j.biomaterials.2009.05.038. Epub 2009 Jun 10.
4
Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).介孔二氧化硅的合成、氨基官能化及其对Cr(VI)的吸附
J Colloid Interface Sci. 2008 Feb 15;318(2):309-14. doi: 10.1016/j.jcis.2007.09.093. Epub 2007 Oct 9.
5
Substitutions of strontium in mesoporous calcium silicate and their physicochemical and biological properties.介孔硅酸钙中锶的取代及其理化和生物学性质。
Acta Biomater. 2013 May;9(5):6723-31. doi: 10.1016/j.actbio.2013.01.021. Epub 2013 Jan 29.
6
Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics.使用多孔硅酸钙生物活性陶瓷修复兔颅骨缺损
Biomaterials. 2008 Jun;29(17):2588-96. doi: 10.1016/j.biomaterials.2008.03.013. Epub 2008 Apr 1.
7
Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.生物活性介孔硅灰石-聚己内酯复合支架的制备与表征
Biomaterials. 2009 Feb;30(6):1080-8. doi: 10.1016/j.biomaterials.2008.10.046. Epub 2008 Nov 18.
8
CaSiO₃ microstructure modulating the in vitro and in vivo bioactivity of poly(lactide-co-glycolide) microspheres.硅酸钙微结构调控聚(乳酸-共-乙醇酸)微球的体外和体内生物活性。
J Biomed Mater Res A. 2011 Jul;98(1):122-31. doi: 10.1002/jbm.a.33092. Epub 2011 May 4.
9
In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics.硅酸钙、硅酸二镁和磷酸三钙生物陶瓷的体外降解、生物活性及细胞相容性
J Biomater Appl. 2009 Aug;24(2):139-58. doi: 10.1177/0885328208094745. Epub 2008 Sep 18.
10
Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications.合成具有大比表面积的生物相容性介孔 Fe(3)O(4)纳米/微球,用于磁共振成像和治疗应用。
ACS Appl Mater Interfaces. 2011 Feb;3(2):237-44. doi: 10.1021/am1012358. Epub 2011 Jan 13.

引用本文的文献

1
Extrusion 3D-printed tricalcium phosphate-polycaprolactone biocomposites for quercetin-KCl delivery in bone tissue engineering.挤出成型的磷酸三钙-聚己内酯生物复合材料用于骨组织工程中槲皮素-KCl 的递送。
J Biomed Mater Res A. 2024 Sep;112(9):1472-1483. doi: 10.1002/jbm.a.37692. Epub 2024 Mar 13.
2
3D Printed SiO-Tricalcium Phosphate Scaffolds Loaded with Carvacrol Nanoparticles for Bone Tissue Engineering Application.负载香芹酚纳米颗粒的3D打印二氧化硅-磷酸三钙支架在骨组织工程中的应用
J Med Chem. 2024 Feb 22;67(4):2745-2757. doi: 10.1021/acs.jmedchem.3c01884. Epub 2023 Dec 26.
3
Production and Characterization of Calcium Silica Aerogel Powder as a Food Additive.
作为食品添加剂的硅酸钙气凝胶粉末的制备与表征
ACS Omega. 2023 Mar 20;8(12):11479-11491. doi: 10.1021/acsomega.3c00358. eCollection 2023 Mar 28.
4
Mesoporous calcium silicate nanoparticles for superficial dental tissue reconstruction, and .用于浅表牙齿组织重建的介孔硅酸钙纳米颗粒,以及…… (原文似乎不完整)
RSC Adv. 2021 Jul 14;11(40):24681-24693. doi: 10.1039/d1ra02114a. eCollection 2021 Jul 13.
5
Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation.介孔生物活性玻璃在癌症诊断和治疗中的应用:刺激响应、毒性、免疫原性及临床转化。
Adv Sci (Weinh). 2022 Jan;9(2):e2102678. doi: 10.1002/advs.202102678. Epub 2021 Nov 19.
6
Development and Characterization of Polyester and Acrylate-Based Composites with Hydroxyapatite and Halloysite Nanotubes for Medical Applications.用于医学应用的含羟基磷灰石和埃洛石纳米管的聚酯和丙烯酸酯基复合材料的开发与表征
Polymers (Basel). 2020 Jul 29;12(8):1703. doi: 10.3390/polym12081703.
7
Improvement of physico-chemical properties of dextran-chitosan composite scaffolds by addition of nano-hydroxyapatite.通过添加纳米羟基磷灰石改善葡聚糖-壳聚糖复合支架的物理化学性质。
Sci Rep. 2018 Aug 15;8(1):12180. doi: 10.1038/s41598-018-30720-2.
8
High drug-loading nanomedicines: progress, current status, and prospects.高载药量纳米药物:进展、现状与展望
Int J Nanomedicine. 2017 May 31;12:4085-4109. doi: 10.2147/IJN.S132780. eCollection 2017.
9
Bioactive mesoporous wollastonite particles for bone tissue engineering.用于骨组织工程的生物活性介孔硅灰石颗粒
J Tissue Eng. 2016 Nov 24;7:2041731416680319. doi: 10.1177/2041731416680319. eCollection 2016 Jan-Dec.
10
Electrically polarized biphasic calcium phosphates: adsorption and release of bovine serum albumin.电双相磷酸钙:牛血清白蛋白的吸附与释放。
Langmuir. 2010 Nov 16;26(22):16625-9. doi: 10.1021/la101851f. Epub 2010 Oct 12.